The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2023 1
2021 1

Japan 3

Journal Article 3

Dispatch 2

1 - 3 of 3 Results

Refine Results

Refine Results:

Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January–May 20201

CITE Title : Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January–May 20201 Personal Author(s) : Kawashima, Takayuki;Nomura, Shuhei;Tanoue, Yuta;Yoneoka, Daisuke;Eguchi, Akifumi;Ng, Chris Fook Sheng;Matsuura, Kentaro;Shi, Shoi;Makiyama, Koji;Uryu, Shinya;Kawamura, Yumi;Takayanagi, Shinichi;Gilmour, Stuart;Miyata, Hiroaki;Sunagawa, Tomimasa;Takahashi, Takuri;Tsuchihashi, Yuuki;Kobayashi, Yusuke;Arima, Yuzo;Kanou, Kazuhiko;Suzuki, Motoi;Hashizume, Masahiro; Published Date : 03/01/2021 Source : Emerg Infect Dis. 27(3):789-795 URL : https://stacks.cdc.gov/view/cdc/104047 Kawashima, Takayuki et al. (2021). Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January–May 20201. 27(3). Kawashima, Takayuki et al. "Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January–May 20201" 27, no. 3 (2021) Kawashima, Takayuki et al. "Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January–May 20201" vol. 27, no. 3, 2021 Export RIS Citation Information.

:

Kawashima, Takayuki ;

Nomura, Shuhei

03/01/2021 | Emerg Infect Dis. 27(3):789-795

:

To provide insight into the mortality burden of coronavirus disease (COVID-19) in Japan, we estimated the excess all-cause deaths for each week during...
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022

CITE Title : Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022 Personal Author(s) : Kinoshita, Ryo;Arashiro, Takeshi;Kitamura, Noriko;Arai, Satoru;Takahashi, Koki;Suzuki, Tadaki;Suzuki, Motoi;Yoneoka, Daisuke; Published Date : 9 2023 Source : Emerg Infect Dis. 2023; 29(9):1868-1871 URL : https://stacks.cdc.gov/view/cdc/133580 Kinoshita, Ryo et al. (2023). Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022. 29(9). Kinoshita, Ryo et al. "Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022" 29, no. 9 (2023) Kinoshita, Ryo et al. "Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022" vol. 29, no. 9, 2023 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Arashiro, Takeshi

9 2023 | Emerg Infect Dis. 2023; 29(9):1868-1871

:

A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced se...
Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023

CITE Title : Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023 Personal Author(s) : Kinoshita, Ryo;Miyamoto, Sho;Sakuraba, Shoko;Sugihara, Jun;Suzuki, Motoi;Suzuki, Tadaki;Yoneoka, Daisuke; Published Date : 6 2024 Source : Emerg Infect Dis. 2024; 30(6):1267-1270 URL : https://stacks.cdc.gov/view/cdc/156981 Kinoshita, Ryo et al. (2024). Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023. 30(6). Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" 30, no. 6 (2024) Kinoshita, Ryo et al. "Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023" vol. 30, no. 6, 2024 Export RIS Citation Information.

:

Kinoshita, Ryo ;

Miyamoto, Sho

6 2024 | Emerg Infect Dis. 2024; 30(6):1267-1270

:

We assessed SARS-CoV-2 seroprevalence in Japan during July-August 2023, with a focus on 2 key age groups, 0-15 and >80 years. We estimated overall ser...